News for Opthea Limited (OPT.AX)

Good Afternoon and welcome to HotCopper’s Market Close, I’m Jonathon Davidson.The ASX200 receded further just below the 8,100pts mark as the XJO continues to digest ongoing tariff implications.

Baseline angiographic lesion characteristics predictive of clinical response Published in peer-reviewed journal Ophthalmic Surgery, Lasers and Imaging Reti

Cash and cash equivalents of $131.9M as of December 31, 2024 Cash runway extends through anticipated topline data readouts of COAST (early 2Q CY25) and ShORe (

Three consecutive commercial-scale drug product batches successfully produced Supports potential sozinibercept BLA filing in 1H CY2026 MELBOURNE, Australia

COAST Phase 3 trial evaluates superiority and safety of sozinibercept combined with aflibercept in wet AMD Company confirms topline results for COAST a

We recently compiled a list of the 10 Best Long Term ASX Stocks to Buy Now. In this article, we are going to take a look at where Opthea Limited (NASDAQ:OPT) stands against the other long term ASX stocks...

**media[534928]**

MELBOURNE, Australia and PRINCETON, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/OPT, ”œOpthea”, the ”œCompany”), a clinical-stage biopha

We recently compiled a list of the 10 Best ASX Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Opthea Limited (NASDAQ:OPT) stands against other best ASX...

A lift in the iron ore price has driven big miners higher; Fortescue was the biggest winner, up 2.7%, followed by BHP, up 1.4% and Rio Tinto, up 0.8%.

**media[509148]**

**media[507938]**

Phase 1b clinical data underpins sozinibercept's potential as a novel, first-in-class VEGF-C/D ”˜trap' to improve visual and anatomic outcomes in DME Publis

Opthea has jumped to 77cps after having its diabetic eye drug of interest further validated as a potential treatment in a scientific paper.

**media[476519]**

MELBOURNE, Australia and PRINCETON, N.J., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/OPT, ”œOpthea”, the ”œCompany”), a clinical-stage biopha

**media[467153]**

Opthea adds Kathy Connell to Board of Directors

**media[438222]**